Journal of Circulating Biomarkers’ authors to get a discount when registering for the Cambridge Healthtech Institute's 7th Annual Predictive Cancer Biomarkers conference

July 7, 2014

We would like to inform all of our Journal of Circulating Biomarkers' (JCB) authors that the journal is partnering with Predictive Cancer Biomarkers, Part of Next Generation Dx Summit - Cambridge Healthtech Institute's Seventh Annual Predictive Cancer Biomarkers conference - to be held this August 19-21 at Capital Hilton Hotel, Washington, DC.

The Journal of Circulating Biomarkers authors will be able to register for the conference at a 10% discounted rate by using the keycode 1480JBMK (Discount applies to new registrations only and cannot be combined with other offers. Applicable to authors of the Journal of Circulating Biomarkers only).

The event will focus on functionalizing cancer genomics by identifying and prioritizing cancer biomarkers, addressing techniques for interrogating cancer genes, and examining how to use next-generation sequencing to guide treatment. Circulating tumor cells and DNA, the next generation of predictive biomarkers, will also be explored with particular emphasis on their viability as a diagnostic and prognostic tool.

If you are a JCB author and would like to receive more information in regard to this conference and the registration, feel free to contact us at jcb@intechopen.com.